SURF - Surface Oncology, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
24,685
59,417
12,826
6,632
Cost of Revenue
-
-
-
-
Gross Profit
-
-
-
-
Operating Expenses
Research Development
50,982
52,492
47,783
20,492
Selling General and Administrative
20,318
16,076
11,033
4,144
Total Operating Expenses
71,300
68,568
58,816
24,636
Operating Income or Loss
-46,615
-9,151
-45,990
-18,004
Interest Expense
-
-
-
-
Total Other Income/Expenses Net
-
2,554
-
-
Income Before Tax
-43,570
-6,597
-45,377
-17,453
Income Tax Expense
-
-
-
-
Income from Continuing Operations
-43,570
-6,597
-45,377
-17,453
Net Income
-43,570
-6,597
-45,377
-17,453
Net Income available to common shareholders
-43,570
-6,608
-45,377
-17,494
Reported EPS
Basic
-
-0.33
-2.35
-0.90
Diluted
-
-0.33
-2.35
-0.90
Weighted average shares outstanding
Basic
-
19,991
19,338
19,338
Diluted
-
19,991
19,338
19,338
EBITDA
-
-7,804
-45,026
-17,673